---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-23-001357"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2023-08-23T23:59:59+00:00"
generated_at: "2026-06-11T04:38:40.085401+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Agenus cuts workforce 25%, pauses non-core programs to focus on BOT/BAL

## Summary
- Workforce reduction of ~25% expected to save $2.8M by year-end; severance cost ~$1.4M.
- Total savings of ~$40M by end of 2023 from halting non-BOT/BAL preclinical and clinical programs.
- Partner-funded programs unaffected; first BOT/BAL regulatory filing targeted in 2024.
- Restructuring supports sped-up registration and commercialization of lead immunotherapy.

## SEC filing metadata
- accession: 0001157523-23-001357
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2023-08-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000115752323001357/0001157523-23-001357-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000115752323001357/a53543827.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-23-001357
- JSON: https://secwatch.observer/filing/0001157523-23-001357.json
- Plain text: https://secwatch.observer/filing/0001157523-23-001357.txt

## Key facts
- Restructurings & Charges
  AGENUS INC announced a restructuring with charges of approximately $1.4 million affecting Agenus Inc. (excluding its independently operating subsidiaries) (approximately 25%).
  - Type: restructuring
  - Charge: approximately $1.4 million
  - Affected area: Agenus Inc. (excluding its independently operating subsidiaries)
  - Headcount: approximately 25%
  source text: As part of this effort, Agenus Inc. (excluding its independently operating subsidiaries) is reducing its workforce by approximately 25%, which the company expects to result in savings of approximately $2.8 million by year-end, after accounting for the cost of the workforce reduction of approximately $1.4 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1098972/000115752323001357/0001157523-23-001357-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.